39 Results for "

CD30

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "CD30" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P99151
CAS No.: 2088770-90-3
Synonyms: CAC-10

Research Areas:  

Cancer

Brentuximab (CAC-10) is a chimeric antibody targeting CD30. Brentuximab is conjugated with Monomethyl auristatin E (MMAE) (HY-15162) to form the antibody-drug conjugate Brentuximab vedotin (HY-P99107A). Brentuximab can be used for the research of cancer, such as lymphoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99107A
CAS No.: 914088-09-8
Research Areas:  

Cancer

Brentuximab vedotin (solution) (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). The antibody portion is Brentuximab (HY-P99151), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Brentuximab vedotin (solution) inhibits CD30-positive cells with an IC50 of 2.5 ng/mL. Brentuximab vedotin (solution) can be used for the research of relapsed and refractory Hodgkin lymphoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70023
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuTumor necrosis factor receptor superfamily member 8/CD30, His; Tumor necrosis factor receptor superfamily member 8; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; CD30; TNFRSF8
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P990710
CAS No.: 2738880-26-5
Synonyms: AFM13

Target:  

TNF Receptor

Research Areas:  

Cancer

Acimtamig (AFM13) is a CD30/CD16A bispecific innate cell engager. Acimtamig binds to the CD16A expressed on natural killer (NK) cells and binds to CD30 on CD30-expressing tumor cells, thereby selectively cross-linking tumor and NK cells. Acimtamig can be used for the study of eripheral T-cell lymphoma (PTCL) .
loading...
    loading...
Cat. No.: HY-P99669
CAS No.: 640735-09-7
Synonyms: MDX-060

Target:  

TNF Receptor

Research Areas:  

Cancer

Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) .
loading...
    loading...
Cat. No.: HY-160649
CAS No.: 1599439-52-7
Research Areas:  

Cancer

MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC50 of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-P991638

Target:  

TNF Receptor

Research Areas:  

Cancer

XmAb-2513 is a humanized monoclonal antibody inhibitor targeting CD30. XmAb-2513 has significant anti-proliferative activity and superior antibody-dependent cell-mediated cytotoxicity (ADCC) as well as antibody-dependent cell-mediated phagocytosis (ADCP). XmAb-2513 can be used for hematologic malignancies like Hodgkin Lymphoma (HL) and Anaplastic Large Cell Lymphoma (ALCL) research .
loading...
    loading...
Cat. No.: HY-P991553

Target:  

TNF Receptor Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

HeFi-1 is a mouse anti-CD30 IgG1 monoclonal antibody. HeFi-1 recognizes the ligand-binding site on CD30. HeFi-1 can inhibit the growth of tumor cells with high expression of CD30. HeFi-1 can induce eosinophil apoptosis. HeFi-1 can be used for researches on cancer or inflammation conditions such as anaplastic large-cell lymphoma (ALCL) and asthma .
loading...
    loading...
Cat. No.: HY-P991512

Target:  

Apoptosis

Research Areas:  

Cancer

SGN-30 is a chimeric antibody derived from a mouse antihuman CD30 antibody, AC10, with the variable regions of AC10 and human α 1 heavy chain and κ light chain constant regions. SGN-30 induces apoptosis and cell-cycle arrest in cancer cells. SGN-30 can be used for the study of Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) .
loading...
    loading...
Cat. No.: HY-177823
Target:  

TNF Receptor

Research Areas:  

Cancer

C2NP sodium is a single-strand DNA aptamer that targets CD30. The multivalent C2NP is able to induce oligomerization of CD30 receptors and, in effect, activate downstream signaling, which led to apoptosis of anaplastic large cell lymphoma (ALCL) cells.
loading...
    loading...
Cat. No.: HY-180412
CAS No.: 226072-63-5
Synonyms: BB-3644
Target:  

MMP

Research Areas:  

Cancer

Solimastat (BB-3644) is a potent metalloproteinase (MMP) inhibitor that blocks constitutive and antibody-stimulated CD30 shedding from cell surfaces with an IC50 of 180 nM. Solimastat enhances persistence of anti-CD30 antibody Ki-3 on cells and favors its internalization. Solimastat enhances cytotoxic activity of Ki-3.dgA towards CD30 + L540 cells. Solimastat can be used for the research of CD30 + malignancies .
loading...
    loading...
Cat. No.: HY-P992404

Target:  

TNF Receptor

Research Areas:  

Cancer

MDX-1401 is a fully human IgG1 (κ isotype) monoclonal antibody against CD30, with a Kd value of 0.83 nmol/L. MDX-1401 induces antibody-dependent cellular cytotoxicity in CD30-expressing cells and inhibits tumor growth in CD30 + lymphoma xenograft models. MDX-1401 can be used in research related to malignant lymphoma and Hodgkin lymphoma .
loading...
    loading...
Cat. No.: HY-P81645
Synonyms: CD30; D1S166E; KI1; Tnfrsf8

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P70075
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuTumor necrosis factor receptor superfamily member 8/TNFRSF8, His; Tumor necrosis factor receptor superfamily member 8; CD30L receptor; Lymphocyte activation antigen CD30; CD30; Tnfrsf8
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700433
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuTumor necrosis factor receptor superfamily member 8/CD30, His; Tumor necrosis factor receptor superfamily member 8; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; CD30; TNFRSF8
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P705115
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; TNFRSF8
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P701265
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF8; CD30; D1S166E; Ki-1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P72354
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; TNFRSF8
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700673
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CD30; CD30KI-1; CD30L receptor; TNFRSF8; D1S166EKi-1; CD30KI-1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P78405
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CD153; CD30 Ligand; CD30L; CD30-L; CD30LGMGC138144; TNFSF8; CD30LG
Species:  
Source:  
loading...
    loading...